Inclusion Criteria:~* Participants in the early alzheimer's disease (AD) spectrum must have a global Clinical
Dementia Rating Scale( CDR) score of 0 (asymptomatic at risk for AD) to 0.5 prodromal AD (pAD) inclusive~*
Participants must have evidence of amyloid pathology by means of either: a) low Cerebrospinal Fluid (CSF) ABeta
1-42 levels at screening; b) a positive amyloid positron emission tomography (PET) scan at screening (depending
on the site's PET capability) by visual read~* Participants must have a body mass index between 18 and 35
kilogram per square meter (kg/m\^2), inclusive, at screening~* Participants must be otherwise healthy for their
age group or medically stable with or without medication on the basis of physical examination, medical history,
vital signs, and 12-lead ECG performed at screening or at baseline. If there are abnormalities, they must be
consistent with the underlying illness in the study population and not a potential cause of cognitive
impairment, with written concurrence with the sponsor's medical monitor~* Before randomization, a woman must be
not of childbearing potential: postmenopausal (greater than or equal to \[â‰¥\] 50 years of age with amenorrhea
for at least 12 months; permanently sterilized \[e.g., tubal occlusion, hysterectomy, bilateral
salpingectomy\]); or otherwise be incapable of pregnancy. In case of questionable status qualified personal of
the sponsor should be consulted to decide on the potential for inclusion of the participant~
